These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31814915)

  • 1. PiggyBac transposon system with polymeric gene carrier transfected into human T cells.
    Zheng Y; Li ZR; Yue R; Fu YL; Liu ZY; Feng HY; Li JG; Han SY
    Am J Transl Res; 2019; 11(11):7126-7136. PubMed ID: 31814915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells.
    Kaštánková I; Štach M; Žižková H; Ptáčková P; Šmilauerová K; Mucha M; Šroller V; Otáhal P
    Mol Ther Methods Clin Dev; 2021 Dec; 23():119-127. PubMed ID: 34631931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR T Cell Generation by
    Bishop DC; Caproni L; Gowrishankar K; Legiewicz M; Karbowniczek K; Tite J; Gottlieb DJ; Micklethwaite KP
    Mol Ther Methods Clin Dev; 2020 Jun; 17():359-368. PubMed ID: 32071928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained high level transgene expression in mammalian cells mediated by the optimized
    Chen X; Cui J; Yan Z; Zhang H; Chen X; Wang N; Shah P; Deng F; Zhao C; Geng N; Li M; Denduluri SK; Haydon RC; Luu HH; Reid RR; He TC
    Genes Dis; 2015 Mar; 2(1):96-105. PubMed ID: 25815368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes.
    Nakazawa Y; Saha S; Galvan DL; Huye L; Rollins L; Rooney CM; Wilson MH
    J Immunother; 2013 Jan; 36(1):3-10. PubMed ID: 23211626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.
    Cooney AL; Singh BK; Sinn PL
    Mol Ther; 2015 Apr; 23(4):667-74. PubMed ID: 25557623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
    Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
    Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposons: Moving Forward from Preclinical Studies to Clinical Trials.
    Tipanee J; VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1087-1104. PubMed ID: 28920716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies.
    Tsukahara T; Iwase N; Kawakami K; Iwasaki M; Yamamoto C; Ohmine K; Uchibori R; Teruya T; Ido H; Saga Y; Urabe M; Mizukami H; Kume A; Nakamura M; Brentjens R; Ozawa K
    Gene Ther; 2015 Feb; 22(2):209-15. PubMed ID: 25427612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in
    Morita D; Nishio N; Saito S; Tanaka M; Kawashima N; Okuno Y; Suzuki S; Matsuda K; Maeda Y; Wilson MH; Dotti G; Rooney CM; Takahashi Y; Nakazawa Y
    Mol Ther Methods Clin Dev; 2018 Mar; 8():131-140. PubMed ID: 29687032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.
    Katayama H; Yasuchika K; Miyauchi Y; Kojima H; Yamaoka R; Kawai T; Yukie Yoshitoshi E; Ogiso S; Kita S; Yasuda K; Sasaki N; Fukumitsu K; Komori J; Ishii T; Uemoto S
    Sci Rep; 2017 Mar; 7():44498. PubMed ID: 28295042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of transposase on the transposition activity of piggyBac transposon transfected into Toxoplasma gondii].
    Song XS; Wei F; Zhang YG; Cao LL; Liu Q
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):244-5. PubMed ID: 24812869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantum pBac: An effective, high-capacity piggyBac-based gene integration vector system for unlocking gene therapy potential.
    Hua WK; Hsu JC; Chen YC; Chang PS; Wen KK; Wang PN; Yang WC; Shen CN; Yu YS; Chen YC; Cheng IC; Wu SC
    FASEB J; 2023 Sep; 37(9):e23108. PubMed ID: 37534940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PiggyBac transposon-mediated gene transfer in human cells.
    Wilson MH; Coates CJ; George AL
    Mol Ther; 2007 Jan; 15(1):139-45. PubMed ID: 17164785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.
    Ramanayake S; Bilmon I; Bishop D; Dubosq MC; Blyth E; Clancy L; Gottlieb D; Micklethwaite K
    Cytotherapy; 2015 Sep; 17(9):1251-67. PubMed ID: 26212611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.
    Cunningham SC; Siew SM; Hallwirth CV; Bolitho C; Sasaki N; Garg G; Michael IP; Hetherington NA; Carpenter K; de Alencastro G; Nagy A; Alexander IE
    Hepatology; 2015 Aug; 62(2):417-28. PubMed ID: 26011400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing piggyBat-a transposase for genetic modification of T cells.
    Sutrave G; Xu N; Tang TCY; Dolnikov A; Gloss B; Gottlieb DJ; Micklethwaite KP; Gowrishankar K
    Mol Ther Methods Clin Dev; 2022 Jun; 25():250-263. PubMed ID: 35474955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The piggyBac transposon is an integrating non-viral gene transfer vector that enhances the efficiency of GDEPT.
    Kang Y; Zhang XY; Jiang W; Wu CQ; Chen CM; Gu JR; Zheng YF; Xu CJ
    Cell Biol Int; 2009 Apr; 33(4):509-15. PubMed ID: 19353779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.
    Bishop DC; Xu N; Tse B; O'Brien TA; Gottlieb DJ; Dolnikov A; Micklethwaite KP
    Mol Ther; 2018 Aug; 26(8):1883-1895. PubMed ID: 29861327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous antigen-presenting cells efficiently expand
    Nakamura K; Yagyu S; Hirota S; Tomida A; Kondo M; Shigeura T; Hasegawa A; Tanaka M; Nakazawa Y
    Mol Ther Methods Clin Dev; 2021 Jun; 21():315-324. PubMed ID: 33898630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.